Sage Journals: Discover world-class research

Retricted access

Other

First published 2015-3

The First Paediatric Use Marketing Authorisation

John Watson, Kulminder Nowacki

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2007-1

What is the Value of Authorised Generic Agreements? Assessments on the French Market

Jean-Michel Peny, Jean-Pierre Covilard

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Research article

First published 2013-2

EU marketing authorization subsequent to dissolution of the transferor and prior to effective transfer

Lucyne Ghazarian, Christian Koenig

Pharmaceuticals Policy and Law

Retricted access

Research article

First published 2005-4

Impact of Court Cases on Summary of Product Characteristics Harmonisation

Richard Milchior

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Free access

Research article

First published 2000-04

Preclinical assessments of European Union marketing authorisation applications for aimmunomodulatory biopharmaceuticals

U Liminga

Human & Experimental Toxicology

Retricted access

Research article

First published 2003-6

THe Latest Thinking on Best Strategies for Use of Supplementary Certificates

Julian Hitchcock, Bülent Tugal

Journal of Medical Marketing: Device,Diagnostic and Pharmaceutical Marketing

Retricted access

Research article

First published 2012-3

Overcoming challenges in market access of generic medicines in the European Union

Pieter Dylst, Arnold Vulto, Steven Simoens

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Other

First published 2015-1

Specific marketing authorisation dossiers and requirements

A.G. Asuero

Pharmaceuticals Policy and Law

Retricted access

Research article

First published 2011-2

The extension of the exclusive right to pharmaceuticals under the European law: The Supplementary Protection Certificate

Fidel Porcuna de la Rosa

Pharmaceuticals Policy and Law

Open access

Research article

First published 2018

Accesso precoce al mercato: dalle approvazioni condizionate di EMA agli accordi negoziali particolari di AIFA

Federico Villa, Claudio Jommi, Armando Genazzani [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Search results